Volume 18, Number 9—September 2012
Multiple Synchronous Outbreaks of Puumala Virus, Germany, 2010
To investigate 2,017 cases of hantavirus disease in Germany, we compared 38 new patient-derived Puumala virus RNA sequences identified in 2010 with bank vole–derived small segment RNA sequences. The epidemic process was driven by outbreaks of 6 Puumala virus clades comprising strains of human and vole origin. Each clade corresponded to a different outbreak region.
Human hantavirus disease is manifested as hemorrhagic fever with renal syndrome (HFRS) in Asia, Europe, and most probably Africa (1). Since 2001, laboratory-confirmed cases of HFRS in Germany, by law, must be reported by local health authorities to the Robert Koch Institute in Berlin, the central federal institution responsible for disease control and prevention. Approximately 200 HFRS cases/year are reported in nonepidemic years (incidence 0.25 cases/100,000 persons).
Local outbreaks of HFRS were reported in 2004–2005, a large outbreak with 1,688 cases was reported in 2007, and 2,017 cases were reported in 2010 (2–4). In 2010, the total HFRS incidence in Germany increased to 2.47 cases/100,000 persons. This increase was caused by outbreaks in specific regions; administrative districts in these regions reported incidences of <80 cases/100,000 persons (Technical Appendix [PDF - 34 KB - 2 pages]). In contrast to previous outbreaks (5), the 2010 outbreak did not lead to increased incidence of HFRS being reported in countries neighboring Germany, such as Belgium (www.wiv-isp.be/epidemio/labo) and France (www.invs.sante.fr/fr/Dossiers-thematiques/Maladies-infectieuses/Zoonoses), which indicated the distinctive features of this outbreak in Germany.
Although 3 hantaviruses, Puumala virus (PUUV), Dobrava-Belgrade virus, and Tula virus circulate in rodent hosts in Germany and can infect humans (6–8), most hantavirus infections in humans are caused by PUUV. The natural reservoir of PUUV, the bank vole (Myodes glareolus), is widely distributed in Germany and other countries in Europe. Bank vole abundance fluctuates every few years with ≈3–4 years between maximum peak densities of up to several hundred animals per hectare (9). Years with high vole densities and increased numbers of registered human hantavirus infections were preceded by years of intense coverage with beech mast (nuts of the European beech tree [Fagus sylvatica]) (10).
Diagnosis of hantavirus infection in humans is usually based on serologic testing. Since 1994, only 22 human-derived PUUV sequences have been identified in Germany. We conducted molecular epidemiologic analysis of the 2010 outbreak in Germany by compiling 38 new PUUV sequences of human origin, which were compared with bank vole–derived small (S) segment RNA sequences from the different outbreak regions.
We established a countrywide alert network that included several physicians and diagnostic laboratories. This network enabled assessment of serum samples from patients during the early clinical phase of infection.
A total of 491 serum samples were tested for antibodies to hantavirus. Of these samples, 377 were positive for IgG against PUUV, of which 330 were positive for IgM against PUUV by an in-house ELISA (11) and immunoblot assay (recomLine Bunyavirus; Mikrogen, Neuried, Germany). These acute-phase antibody-positive samples were then screened by using a nested pan hantavirus reverse transcription PCR (12) specific for a conserved region within the polymerase gene (large genomic segment). Using this approach, we identified 102/330 IgM- and IgG-positive samples that were PCR positive. Sequencing of this large segment region confirmed infection by PUUV.
To differentiate virus strains within the PUUV species, a higher variable nucleotide sequence was targeted by amplification of a 504-nt fragment of the genomic S segment encoding the nucleocapsid protein (13). Using this approach, we found that 38 of 102 PUUV-positive samples were S segment positive. Nucleotide sequences of these 38 samples were determined and used for molecular phylogenetic analysis. The dataset also included sequences obtained from human and M. glareolus vole samples collected in previous years and from voles captured during the 2010 outbreak. Rodent trapping was performed after permission was obtained from Federal State authorities (permit no. NRW 20.09.210, BW 35-9185.82/0261).
Residences of patients in Germany from whom viral sequences were obtained and corresponding rodent trapping sites are shown in Figure 1. Results of molecular phylogenetic analysis of these strains are shown in Figure 2. In addition to 4 molecular clades (Swabian Jura, clade 1; Bavarian Forest, clade 2; Spessart Forest, clade 3; and Münsterland, clade 6) found during the 2007 outbreak, 2 novel clades (North East Hesse, clade 4; and Teutoburg Forest, clade 5) were defined. All 6 clades comprised human-derived and vole-derived sequences.
Identification of new PUUV clades in 2010 was associated with a higher incidence of human disease than in 2007. For example, in the Federal State of Hesse, incidence increased from 0.35 cases/100,000 persons in 2007 to 2.80 cases/100,000 persons in 2010. This increase in cases enabled us to collect blood specimens from patients shortly after clinical onset of disease, characterize these specimens, and define a new PUUV clade (North East Hesse, clade 4).
To analyze diversity within and between different clades, we aligned each clade and calculated mean pairwise amino acid and nucleotide identities. In addition, we identified the consensus sequence of each clade and compared each with those of other clades (Table). Sequences within 1 clade show pairwise amino acid identities >97% and nucleotide identities >96%. Identities between clades range from 90.3% (Swabian Jura vs. Spessart Forest) to 97.7% (Münsterland vs. Teutoburg Forest) on the amino acid level and 81.3% (Teutoburg Forest vs. Swabian Jura) to 89.0% (Münsterland vs. Teutoburg Forest) on the nucleotide sequence level.
Within a particular molecular clade, virus strains from localities near each other could be differentiated. For example, within PUUV strains from the Bavarian Forest, which has been known as an outbreak region since 2004 (13,14), newly characterized strains 10 Mu Eb51 and 10 Mu Eb14 (Bavarian Forest; Figure 1, Figure 2) originated from localities only 25 km apart. Because migration distances >1 km for bank voles are efficiently prevented by natural and artificial barriers (15), local vole populations are likely associated with specific PUUV strains.
Three years after a large 2007 PUUV outbreak, a subsequent epidemic with >2,000 human cases occurred in Germany. On the basis of beech mast coverage in 2009, growth of the reservoir rodent population in 2010 was expected. Model monitoring studies in July 2010 found mean ± SD bank vole densities of <141 ± 13 voles/hectare in investigated outbreak regions. PUUV seroprevalence in these bank vole populations was >40%. Bank vole densities in the same regions decreased to <15 voles/hectare in April 2011 (D. Reil, U.M. Rosenfeld, unpub. data).
Phylogenetic analysis of the involved PUUV strains identified 6 clades comprising virus strains of human and vole origin. Each clade clearly corresponds to a different outbreak region. High molecular similarities of human- and rodent-derived PUUV sequences from the same geographic origin and their clear molecular distinction from viruses of neighboring regions indicate spatial evolution of each virus clade. Thus, we conclude that the 2010 epidemic was not caused by countrywide spread of the same virus but resulted from multiple local outbreaks associated with simultaneous increases in densities and infection rates of bank voles in the different geographic regions.
At least for the investigated 504-nt S segment region, no evidence was found that viruses had undergone changes over time or as a result of rodent-to-human transmission. Lack of human-to-human transmission, local distribution of bank voles, and a high degree of identity between viruses of human and rodent origin enabled us to allocate certain virus strains to defined geographic regions. Future investigations may enable generation of risk maps with higher resolution and establishment of more sophisticated preventive measures in high-risk areas.
Dr Ettinger is a research scientist at the National Consultation Laboratory for Hantaviruses at the Charité Medical School in Berlin. His research interests focus on the molecular epidemiology of hantaviruses and HIV.
We thank the physicians, diagnostic laboratories, and our partners in the network Rodent-borne Pathogens in Germany for providing excellent assistance.
This study was supported by the Robert Koch Institute with funds from the German Ministry of Public Health (grants 1362/1-924, 1362/1-980, 1369-382, 1369-435), the Federal Environment Agency (grant 3710 63 401), and the Vector-borne Infectious Diseases in Climate Change Investigations Network supported by the Bavarian Ministry of Health. H.S.A. is supported by a scholarship from German Academic Exchange Service (grant A/09/90015).
- Krüger DH, Schonrich G, Klempa B. Human pathogenic hantaviruses and prevention of infection. Hum Vaccin. 2011;7:685–93.
- Hofmann J, Meisel H, Klempa B, Vesenbeckh SM, Beck R, Michel D, Hantavirus outbreak, Germany, 2007. Emerg Infect Dis. 2008;14:850–2.
- Robert Koch Institut. SurvStat@RKI [cited 2012 Mar 12]. http://www3.rki.de/SurvStat
- Faber MS, Ulrich RG, Frank C, Brockmann SO, Pfaff GM, Jacob J, Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill. 2010;15:19574.
- Mailles A, Sin MA, Ducoffre G, Heyman P, Koch J, Zeller H. Larger than usual increase in cases of hantavirus infection in Belgium, France and Germany, June 2005. Euro Surveill. 2005;10:E050721.4.
- Maes P, Clement J, Gavrilovskaya I, Van Ranst M. Hantaviruses: immunology, treatment, and prevention. Viral Immunol. 2004;17:481–97.
- Klempa B, Schütt M, Auste B, Labuda M, Ulrich R, Meisel H, First molecular identification of human Dobrava virus infection in central. Eur J Clin Microbiol. 2004;42:1322–5.
- Klempa B, Meisel H, Räth S, Bartel J, Ulrich R, Kruger DH. Occurrence of renal and pulmonary syndrome in a region of northeast Germany where Tula hantavirus circulates. J Clin Microbiol. 2003;41:4894–7.
- Bujalska G. Peak numbers of Clethrionomys glareolus (Schreber 1780) and the mechanisms involved. Pol Ecol Stud. 1995;21:397–411.
- Clement J, Maes P, van Ypersele de Strihou C, van der Groen G, Barrios JM, Verstraeten WW, Beechnuts and outbreaks of nephropathia epidemica (NE): of mast, mice and men. Nephrol Dial Transplant. 2010;25:1740–6.
- Meisel H, Wolbert A, Razanskiene A, Marg A, Kazaks A, Sasnauskas K, Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins. Clin Vaccine Immunol. 2006;13:1349–57.
- Klempa B, Fichet-Calvet E, Lecompte E, Auste B, Aniskin V, Meisel H, Hantavirus in African wood mouse, Guinea. Emerg Infect Dis. 2006;12:838–40.
- Schilling S, Emmerich P, Klempa B, Auste B, Schnaith E, Schmitz H, Hantavirus disease outbreak in Germany: limitations of routine serological diagnostics and clustering of virus sequences of human and rodent origin. J Clin Microbiol. 2007;45:3008–14.
- Essbauer S, Schmidt J, Conraths FJ, Friedrich R, Koch J, Hautmann W, A new Puumala hantavirus subtype in rodents associated with an outbreak of nephropathia epidemica in South-East Germany in 2004. Epidemiol Infect. 2006;134:1333–44.
- Gabriele G, Musolf K. Fragmentation of landscape as a cause for genetic subdivision in bank voles. Conserv Biol. 2000;14:1066–74.
Suggested citation for this article: Ettinger J, Hofmann J, Enders M, Tewald F, Oehme RM, Rosenfeld UM, et al. Multiple synchronous outbreaks of Puumala virus, Germany, 2010. Emerg Infect Dis [serial on the Internet]. 2012 Sep [date cited]. http://dx.doi.org/10.3201/eid1809.111447
1These authors contributed equally to this article.
- Page created: August 16, 2012
- Page last updated: September 05, 2012
- Page last reviewed: September 05, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)